Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzbromarone for respiratory health and quality of life in cystic fibrosis
RBR-5wvg53sPhase 2Not yet recruiting
- Sponsor
- Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of benzbromarone in cystic fibrosis (CF), sponsored by Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS). Planned start May 2021; status: not yet recruiting.
02
Drugs
benzbromarone
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on RBR-5wvg53s.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5wvg53s.